Results for tag: "Urological Cancer Drug"

The Urological Cancer Drug market is a subset of the larger Oncology Drugs market. Urological Cancer Drugs are used to treat cancers of the urinary tract, including bladder, kidney, prostate, and testicular cancers. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Commonly used Urological Cancer Drugs include immunotherapies, targeted therapies, and hormone therapies. Urological Cancer Drugs are typically prescribed by urologists, oncologists, and other healthcare professionals. The market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the Urological Cancer Drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more